163 related articles for article (PubMed ID: 1837471)
1. Favorable results in cancer imaging and therapy using monoclonal antibodies.
Oncology (Williston Park); 1991 Jul; 5(7):108. PubMed ID: 1837471
[No Abstract] [Full Text] [Related]
2. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Cannistra SA
Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
[No Abstract] [Full Text] [Related]
3. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients.
Jusko WJ; Kung LP; Schmelter RF
Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345
[No Abstract] [Full Text] [Related]
4. Lipomas as a potential cause for uptake of In-111 MAb72.3 (Oncoscint CR).
Sakow NK; Japanwalla M; Tuckson WB; Shields RE
Clin Nucl Med; 1996 Apr; 21(4):332-3. PubMed ID: 8925626
[No Abstract] [Full Text] [Related]
5. Diagnostic use of radiolabeled antibodies for cancer.
Harrison KA; Tempero MA
Oncology (Williston Park); 1995 Jul; 9(7):625-31 DISC 634, 636, 641. PubMed ID: 8924373
[TBL] [Abstract][Full Text] [Related]
6. False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma.
Bhatia M; Baron PL; Alderman DF; Gordon L
Clin Nucl Med; 1995 Nov; 20(11):979-80. PubMed ID: 8565379
[TBL] [Abstract][Full Text] [Related]
7. Site of mistletoe injection observed on In-111 OncoScint imaging.
Choe W
Clin Nucl Med; 1997 Feb; 22(2):127. PubMed ID: 9031776
[No Abstract] [Full Text] [Related]
8. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
9. Splenic metastasis from colon carcinoma imaged using In-111 OncoScint.
Pieslor PC; White CA; Varney RR
Clin Nucl Med; 1995 Jun; 20(6):553-4. PubMed ID: 7648747
[No Abstract] [Full Text] [Related]
10. Promising results with radiolabeled monoclonal antibodies.
Oncology (Williston Park); 1991 May; 5(5):151-2. PubMed ID: 1831997
[No Abstract] [Full Text] [Related]
11. Oncoscint for detection of disseminated colorectal and ovarian cancer.
Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
[No Abstract] [Full Text] [Related]
12. Investigators review potential of antibodies in cancer detection and therapy.
Srivastava SC
J Nucl Med; 1987 Feb; 28(2):143-7. PubMed ID: 3806217
[No Abstract] [Full Text] [Related]
13. A practical approach to planar and SPECT imaging of 111In-CYT-103.
Collier BD; Trembath LA; Liu Y; Turoglu HT; Patel N; Thakur S
Targeted Diagn Ther; 1992; 6():191-210. PubMed ID: 1576346
[No Abstract] [Full Text] [Related]
14. OncoScint image atlas.
Maguire RT
Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
[No Abstract] [Full Text] [Related]
15. Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
Gallup DG
Targeted Diagn Ther; 1992; 6():111-24. PubMed ID: 1576342
[No Abstract] [Full Text] [Related]
16. Monoclonal antibody imaging in colon cancer: a transition from basic science to clinical application.
Kim SL; Goldschmid S
Am J Gastroenterol; 1994 Oct; 89(10):1910-2. PubMed ID: 7942701
[No Abstract] [Full Text] [Related]
17. Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
Surwit EA
Targeted Diagn Ther; 1992; 6():125-40. PubMed ID: 1576343
[No Abstract] [Full Text] [Related]
18. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
[No Abstract] [Full Text] [Related]
19. Challenges in immunoscintigraphy of ovarian cancer.
Kim EE; Kasi LP
Gynecol Oncol; 1993 Mar; 48(3):283-4. PubMed ID: 8462895
[No Abstract] [Full Text] [Related]
20. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
